Lamictal CD (Oral)
Generic name:lamotrigine (oral route) [ la-MOE-tri-jeen ]
Drug class:Triazine anticonvulsants
Medically reviewed by Drugs.com. Last updated on Apr 7, 2022.
Cases of life-threatening serious rashes, including Stevens-Johnson syndrome and toxic epidermal necrolysis, or rash-related death have been caused by lamotrigine. The rate of serious rash is greater in pediatric patients than in adults. Additional factors that may increase the risk of rash include: (1) coadministration with valproate; (2) exceeding recommended initial dose of lamotrigine; or (3) exceeding recommended dose escalation for lamotrigine. Benign rashes are also caused by lamotrigine; however, it is not possible to predict which rashes will prove to be serious or life threatening. Lamotrigine should be discontinued at the first sign of rash, unless the rash is clearly not drug related .
Commonly used brand name(s)
In the U.S.
- LaMICtal
- LaMICtal CD
- LaMICtal ODT
- LaMICtal XR
Available Dosage Forms:
- Tablet
- Tablet, Extended Release
- Tablet, Chewable
- Tablet, Disintegrating
Therapeutic Class: Anticonvulsant
Chemical Class: Phenyltriazine
Uses for Lamictal CD
Lamotrigine is used alone or together with other medicines to help control certain types of seizures (eg, partial seizures, tonic-clonic seizures, or Lennox-Gastaut syndrome) in the treatment of epilepsy. This medicine cannot cure epilepsy and will only work to control seizures for as long as you continue to take it. It can also be used in the treatment of bipolar disorder (manic-depressive illness) in adults.
This medicine is available only with your doctor's prescription.
Before using Lamictal CD
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of lamotrigine chewable tablets, disintegrating tablets, tablets for suspension, or tablets in children with certain types of seizures 2 years of age and older. However, safety and efficacy have not been established in children younger than 2 years of age.
Appropriate studies have not been performed on the relationship of age to the effects of lamotrigine extended-release tablets in children with partial seizures younger than 13 years of age. Safety and efficacy have not been established.
Appropriate studies have not been performed on the relationship of age to the effects of lamotrigine chewable tablets, disintegrating t..